Casey Cosgrove
Casey Cosgrove
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Active, not recruiting | Phase 2 | 2026-03-27 | NCT05870761 |